+49 2066 50687-70

Fast identification of disseminated mucormycosis in hematooncologic patients by next-generation sequencing: a case series.

Jan 1, 2021 | Abstracts, Publikationen

Invasive mucormycoses are increasingly emerging and a severe health threat with potentially fatal outcome especially for immunocompromised patients. They are challenging to diagnose: the diagnostic workup includes numerous tests, is time-intensive and frequently invasive. Cultivation is difficult and slow and yet frequently remains negative. Fast diagnosis for a timely treatment is urgently needed. We here describe a case series, where untargeted next-generation sequencing (NGS, with Noscendo’s CE-IVD marked DISQVER® pathogen test) provided identification of moulds in three patients with underlying hematologic malignancies from a standard blood draw within 24h after sample arrival.

Informationen für Ärzte

Präzisere Diagnostik – mehr Wissen: Erfahren Sie mehr über den klinischen Einsatz von DISQVER!

So funktioniert DISQVER

Informationen für medizinische Fachrichtungen



Lesen Sie mehr über Noscendo und DISQVER oder treffen Sie uns auf Fachmessen und Kongressen!

Alle News





DISQVER together – lernen Sie Noscendo kennen!

Über noscendo


Advisory Board